Search

everythinglearnresearchcommunity

for

Search:↓

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

Enzymes called PADIs play a key role in hair growth and loss.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

A new device, IVL-PPF Microsphere®, was created to deliver a hair loss drug for up to 3 months with one injection, potentially replacing daily pills.

Current drug safety systems fail to detect long-term side effects, needing improvements to protect health and trust.

Post-drug syndromes are often overlooked, and better systems and education are needed to improve drug safety.

Understanding patients' views on their illness can help improve their disease management.

EPDS is a rare, chronic scalp condition that's hard to treat and needs better awareness for improved outcomes.

The document concludes that PK/PD modeling is important for determining the safe and effective dosages of drugs.

PICAT is a reliable tool for assessing dermatology residents' skills in PRP procedures for hair loss.

Pegylated interferon-alpha 2a can cause a rare nerve disorder, but early treatment can lead to full recovery.

Post-implantation erythema is a red skin condition after medical device implantation that sometimes goes away on its own.

2h-ICPR can help screen for insulin antibodies in type 2 diabetes patients.

PRP injections with tadalafil and stretching safely improved Peyronie's symptoms but didn't significantly change curvature long-term.

PDRN helps repair tissue and improve wound healing with a high safety profile.

Hair follicle cells help protect against immune attacks by regulating T-cell activity.

LiPADI is a useful tool for monitoring the severity and treatment of lichen planus.

Diphencyprone can cause unexpected and possibly permanent vitiligo.

DPP may help hair regrowth by improving blood vessel function under stress.

PX-12 may help treat psoriasis by blocking inflammation and cell death.

Two new IRAK4-inhibitors effectively reduced skin inflammation and immune response markers in healthy volunteers.

PCE-DP brightens skin and promotes hair growth by enhancing cell growth and reducing melanin uptake.

Immune checkpoint inhibitors can cause scalp inflammation and hair follicle issues.

Current drug safety systems fail to detect long-term side effects, leading to preventable health issues.

Two peptides, RMYYY and VMYMI, may be effective anti-inflammatory drugs.

ICP5249 helps hair grow by activating a specific cell pathway.

IP-PA1 helps grow hair in mice and affects human cell growth-related genes differently than traditional hair growth treatments.

Injectable platelet-rich fibrin improves hair growth and reduces hair loss in women.

PDRN may reduce inflammation and complications in revision rhinoplasty for patients with high fibrinogen levels.